Early-Life Risk for Pathological Anxiety

Tuesday, October 12, 2021, 2:00 pm EDT
Meet the Scientist - October 2021

Early-life anxiety is a risk factor for development of anxiety disorders, depression, and substance abuse. Research has revealed alterations in brain structure and function as well as underlying molecular factors that predispose individuals to develop pathological anxiety. This talk will discuss new treatment approaches that build on these findings, including efforts to increase the plasticity of specific brain circuits implicated in stress-related psychopathology.

Please note that for this webinar, an audio recording, a visual slide presentation or written transcript will not be available after the webinar date. The only way to view this webinar was to attend live at 2:00pm Eastern on October 12, 2021.

Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

Sign up for other upcoming webinars.

View past webinar recordings.

Presented by 
Ned H. Kalin, M.D.
Ned H. Kalin, M.D.
University of Wisconsin – Madison

Hedberg Professor and Chairman, Department of Psychiatry

Director, Health, Emotions Research Institute School of Medicine and Public Health

Scientific Council Member (Joined 2016)

Ned H. Kalin, M.D., is Hedberg Professor and Chair of the Department of Psychiatry at the University of Wisconsin School of Medicine and Public Health. He is the Director of the HealthEmotions Research Institute and the Lane Neuroimaging Laboratory, a Professor in the Department of Psychology at the University of Wisconsin, and an affiliate scientist at the Wisconsin Regional Primate Center and the Harlow Primate Laboratory. He serves as the principal investigator for several ongoing NIH funded research projects and has published over 250 peer-reviewed articles related to the adaptive and maladaptive expression of emotion and anxiety, and the childhood risk to develop anxiety disorders and depression. His research focuses on uncovering basic mechanisms that relate stress to the development of psychopathology and to understanding the mechanisms that cause some children to be vulnerable for the development of anxiety and depression. The aim of his research is to develop novel, neuroscientifically-informed, strategies for the treatment of anxiety disorders with a special focus on early life and preventive interventions for young children.

Moderated by 
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation

President and CEO

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy Award-nominated public television program “Healthy Minds,” and serves as host of the series. The program, which is broadcast nationwide, focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association and as an Associate Clinical Professor of Psychiatry at Columbia University College of Physicians and Surgeons.